The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Items 101–200 of 918
Kleiman, A., Hübner, S., Parkitna, J. M. R., Neumann, A., Hofer, S., Weigand, M. A., Bauer, M., Schmid, W., Schütz, G., Libert, C., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-192112 · Cited by 152
Reddy, T. E., Gertz, J., Crawford, G. E., Garabedian, M. J., & Myers, R. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00062-12 · Cited by 149
“In addition, the AP-1 complex is a well-documented factor known to enhance GR binding (1, 6, 17, 63), and evidence also suggests interactions occur between GR and the CRE binding protein (CREB) (19, 25).”
BackgroundThe GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression
Reily, M. M., Pantoja, C., Hu, X., Chinenov, Y., & Rogatsky, I. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600919 · Cited by 149
“Several models for transcriptional antagonism between these factors and GR have been proposed (reviewed in De Bosscher et al, 2003), ranging from mutual inhibition of DNA binding or competition for a common cofactor, to upregulation of an inhibitor (e.g., IkB or MKP phosphatase) or direct…”
BackgroundEpigenetic modulation of chronic anxiety and pain by histone deacetylation
Tran, L., Schulkin, J., Ligon, C. O., & Greenwood-Van Meerveld, B. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.122 · Cited by 148
Kuo, T., Lew, M. J., Mayba, O., Harris, C. A., Speed, T. P., & Wang, J.-C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111334109 · Cited by 147
“The AP-1 element, which mediates glucocorticoid repression (34), was highly represented in the GBR of glucocorticoid-repressed genes.”
BackgroundGlucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer Cells
Yano, A., Fujii, Y., Iwai, A., Kageyama, Y., & Kihara, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2085 · Cited by 169
Ziegelbauer, K., Gantner, F., Lukacs, N. W., Berlin, A., Fuchikami, K., Niki, T., Sakai, K., Inbe, H., Takeshita, K., Ishimori, M., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706176 · Cited by 146
“GCs inhibit airway inflammation by directly interact- ing with and inhibiting the activity of the transcription factors NF-kB and AP-1 (De Bosscher et al., 2003; Leung & Bloom, 2003).”
Backgroundde Kloet, E. R., Fitzsimons, C. P., Datson, N. A., Meijer, O. C., & Vreugdenhil, E. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.039 · Cited by 162
Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance
Huang, W., & Glass, C. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.191189 · Cited by 140
Single-molecule analysis of steroid receptor and cofactor action in living cells
Paakinaho, V., Presman, D. M., Ball, D. A., Johnson, T. A., Schiltz, R. L., Levitt, P., Mazza, D., Morisaki, T., Karpova, T. S., & Hager, G. L. (2017) · Nature Communications · doi:10.1038/ncomms15896 · Cited by 139
Checks and balances: The glucocorticoid receptor and NFĸB in good times and bad
Bekhbat, M., Rowson, S. A., & Neigh, G. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.001 · Cited by 131
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
Glucocorticoids, genes and brain function
Juszczak, G. R., & Stankiewicz, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.020 · Cited by 153
“…that GCs commonly increased transcription of Nfkbia (Carter et al., 2012; Datson et al., 2013; Gray et al., 2014; Morsink et al., 2006b; Peffer et al., 2014; Sato et al., 2008), consistent with studies applying other methods (Altonsy et al., 2014; De Bosscher et al., 2003; Ing et al., 2014).”
BackgroundResultChronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation
Nunez, S. G., Rabelo, S. P., Subotic, N., Caruso, J. W., & Knezevic, N. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209994 · Cited by 138
“Cortisol is a glucocorticoid hormone secreted at a basal state that follows a pulsatile and oscillatory nature according to the circadian rhythm [18].”
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections
Dijsselbloem, N., Berghe, W. V., Naeyer, A. D., & Haegeman, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.036 · Cited by 150
“[263] De Bosscher K, Vanden Berghe W, Haegeman G.”
BackgroundSelf-citationRole of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis
Beaulieu, É., & Morand, E. F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.59 · Cited by 146
“Glucocorticoids are effective inhibitors of the NFκB pathway, and considerable research directed at understanding the antagonistic effects of glucocorticoids on this pathway has been undertaken”
BackgroundDewint, P., Gossye, V., De Bosscher, K., Vanden Berghe, W., Van Beneden, K., Deforce, D., Van Calenbergh, S., Müller-Ladner, U., Vander Cruyssen, B., Verbruggen, G., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2608 · Cited by 137
“In contrast, the gene-inducing effect of this pathway is down-regulated by the interference of an activated glucocorticoid (GC) receptor (GR) with the activity of NF- B (5).”
BackgroundSelf-citationTargeting inflammation using selective glucocorticoid receptor modulators
Bosscher, K. D., Haegeman, G., & Elewaut, D. S. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.007 · Cited by 181
Self-citationInhibition of NF-κB-dependent Transcription by MKP-1
King, E. M., Holden, N. S., Gong, W., Rider, C. F., & Newton, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028381 · Cited by 130
Tumor suppressor activity of glucocorticoid receptor in the prostate
Yemelyanov, A. Y., Czwornog, J. L., Chebotaev, D. V., Karseladze, A. I., Kulevich, E. E., Yang, X. J., & Budunova, I. V. (2006) · Oncogene · doi:10.1038/sj.onc.1209991 · Cited by 143
“…by GR, transrepression, is in most cases mediated by direct interaction between GR and other TFs or by the crosstalk between GR and other signaling pathways, especially MAPKs (Kassel et al., 2001; Schacke et al., 2002; Bruna et al., 2003; De Bosscher et al., 2003; Necela and Cidlowski, 2004).”
BackgroundChinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133
Impact of Immune-Modulatory Drugs on Regulatory T Cell
Furukawa, A., Wisel, S. A., & Tang, Q. (2016) · Transplantation · doi:10.1097/tp.0000000000001379 · Cited by 137
Genome reading by the NF-κB transcription factors
Mulero, M. C., Wang, V. Y.-F., Huxford, T., & Ghosh, G. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz739 · Cited by 128
Specificity and sensitivity of glucocorticoid signaling in health and disease
Cain, D. W., & Cidlowski, J. A. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.007 · Cited by 127
Eloranta, J. J., Jung, D., & Kullak-Ublick, G. A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0159 · Cited by 133
Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach
Chia, J. K. S., & Chia, A. Y. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.050054 · Cited by 133
Kuningas, M., Rijk, R. H. D., Westendorp, R. G. J., Jolles, J., Slagboom, P. E., & van Heemst, D. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301260 · Cited by 147
Martens, C., Bilodeau, S., Maira, M., Gauthier, Y., & Drouin, J. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0333 · Cited by 128
“Previous studies have demonstrated that GR DBD is essential for interaction with AP-1 (4) and that this interaction is stabilized by the GR C-terminal domain.”
InfluentialHaake, S. M., Dinh, C. T., Chen, S., Eshraghi, A. A., & Water, T. R. V. D. (2009) · Hearing Research · doi:10.1016/j.heares.2009.05.003 · Cited by 139
Liberman, A. C., Refojo, D., Druker, J., Toscano, M., Rein, T., Holsboer, F., & Arzt, E. (2007) · The FASEB Journal · doi:10.1096/fj.06-7452com · Cited by 124
PPARs and other nuclear receptors in inflammation
RIZZO, G., & Fiorucci, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.012 · Cited by 139
Staurengo‐Ferrari, L., Badaro‐Garcia, S., Hohmann, M. S., Manchope, M. F., Zaninelli, T. H., Casagrande, R., & Verri, W. A., Jr. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01536 · Cited by 133
“Moreover, the complex can also interact with other transcription factors such as NFκB (McKay and Cidlowski, 1999; De Bosscher et al., 2003) and Nrf2 (Ki et al., 2005; Kratschmar et al., 2012).”
BackgroundLi, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
Glucocorticoids in the regulation of transcription factors that control cytokine synthesis
Liberman, A. C., Druker, J., Perone, M. J., & ARZT, E. S. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.01.005 · Cited by 148
“GR repress NF-kB IL-8- and ICAM-mediated activation not by interfering with NF-kB DNA binding nor with PIC formation but by inhibition of RNApolII carboxylterminal domain (CTD) Ser-2 phosphorylation [8,47], a key event for cytokine gene transcription.”
BackgroundUrsolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells
Kassi, E. N., Sourlingas, T. G., Spiliotaki, M., Papoutsi, Z., Pratsinis, H., Aligiannis, N., & Moutsatsou, P. (2009) · Cancer Investigation · doi:10.1080/07357900802672712 · Cited by 125
“Upon binding to GCs, GRα changes its conformational shape, dissociates from heat-shock proteins (HSPs), homodimerizes, translocates into nucleus where it interacts directly with its target DNA sequences, the glucocorticoid response elements (GREs), thus resulting in the stimulation of genes (known as transactivation e…”
Vitlic, A., Lord, J. M., & Phillips, A. C. (2014) · AGE · doi:10.1007/s11357-014-9631-6 · Cited by 123
Giembycz, M. A., Kaur, M., Leigh, R., & Newton, R. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707627 · Cited by 135
“…repressive mode of glucocorticoid action is termed transrepression in which the activity of key pro-inflammatory transcription factors, such as nuclear factor-kB and activator protein (AP)-1, is inhibited via direct interactions with ligand-bound GR (Barnes, 2001; De Bosscher et al., 2003).”
BackgroundDifferential targeting of brain stress circuits with a selective glucocorticoid receptor modulator
Zalachoras, I., Houtman, R., Atucha, E., Devos, R., Tijssen, A. M. I., Hu, P., Lockey, P. M., Datson, N. A., Belanoff, J. K., Lucassen, P. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219411110 · Cited by 121
“Anti-inflammatory SGRMs with diminished side effects have been pursued, based on the distinction between GR effects that depend on direct DNA binding and those that take place via protein– protein interactions between the GR and other transcription factors (12).”
BackgroundEndothelial Response to Glucocorticoids in Inflammatory Diseases
Zielińska, K. A., Moortel, L. V., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00592 · Cited by 131
Huijbregts, R. P. H., Helton, E. S., Michel, K. G., Sabbaj, S., Richter, H. E., Goepfert, P., & Hel, Z. (2013) · Endocrinology · doi:10.1210/en.2012-1850 · Cited by 133
Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin
Horowitz, M. A., & Zunszain, P. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12781 · Cited by 110
Structures and mechanism for the design of highly potent glucocorticoids
He, Y., Yi, W., Suino-Powell, K. M., Zhou, X. E., Tolbert, W. D., Tang, X. C., Yang, J., Yang, H., Shi, J., Hou, L., et al. (2014) · Cell Research · doi:10.1038/cr.2014.52 · Cited by 128
DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117
“…translocate to the nucleus, bind to specific DNA sequences and modulate gene transcription (Schaaf and Cidlowski, 2002b; Funder, 1993; Schoneveld et al., 2004; Meijer et al., 2006; Joëls et al., 2006; Joëls, 2006; Pascual-Le Tallec and Lombes, 2005; De Bosscher et al., 2003; Meijer et al., 2006).”
BackgroundNewton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
“Similar mechanistic processes are also thought to explain the repression of AP-1-dependent transcription by glucocorticoids (De Bosscher et al., 2003).”
Zhou, Y., Ling, E., & Dheen, S. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04535.x · Cited by 115
LaLone, C. A., Villeneuve, D. L., Olmstead, A. W., Medlock, E. K., Kahl, M. D., Jensen, K. M., Durhan, E. J., Makynen, E. A., Blanksma, C. A., Cavallin, J. E., et al. (2011) · Environmental Toxicology and Chemistry · doi:10.1002/etc.1729 · Cited by 117
Bougarne, N., Paumelle, R., Caron, S., Hennuyer, N., Mansouri, R., Gervois, P., Staels, B., Haegeman, G., & De Bosscher, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806742106 · Cited by 110
Self-citationInhaled corticosteroids: effects on the airway vasculature in bronchial asthma
Horváth, G., & Wanner, A. (2005) · European Respiratory Journal · doi:10.1183/09031936.06.00048605 · Cited by 127
Can NF-κB be a target for novel and efficient anti-cancer agents?
Olivier, S., Robe, P. A. J. T., & Bours, V. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.023 · Cited by 129
Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2023) · Physiological Reviews · doi:10.1152/physrev.00021.2023 · Cited by 118
p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-κB pathway
Liu, S., Feng, G., Wang, G., & Liu, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.009 · Cited by 115
de KLOET, E. R., & DERIJK, R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.003 · Cited by 109
The use of inhaled corticosteroids in pediatric asthma: update
Hossny, E. M., Rosario, N., Lee, B. W., Singh, M., El-Ghoneimy, D. H., Soh, J. Y., & Souëf, P. N. L. (2016) · World Allergy Organization Journal · doi:10.1186/s40413-016-0117-0 · Cited by 128
“This occurs mainly by down regulation of pro-inflammatory proteins [5, 6].”
BackgroundAnti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
Hollman, D. A. A., Milona, A., van Erpecum, K. J., & van Mil, S. W. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.004 · Cited by 121
“Upon docking of a NR to NF-κB/AP-1, transcription of target genes is inhibited [93].”
BackgroundGlucocorticoid receptor and breast cancer
Vilasco, M., Communal, L., Mourra, N., Courtin, A., Forgez, P., & Gompel, A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1689-6 · Cited by 122
“GR binding to c-Jun homodimers led to gene transactivation, whereas GR binding with c-Jun/c-Fos heterodimers resulted in gene trans-repression [ 56 , 64].”
BackgroundInfluentialLee, I., Shih, R., Lin, C., Chen, J.-T., & Yang, C. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-33 · Cited by 118
“It has been established that various stimuli, such as bacterial infections have been shown to induce AP-1 activity [16].”
BackgroundDu, J., Cheng, B., Zhu, X., & Ling, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002579 · Cited by 128
“Although it has been described that GCs interfere with MAPK signaling pathways, thereby hampering full-blown NF-kB activity, this effect seems to be cell type-dependent (5).”
BackgroundIncreased Glioma Growth in Mice Depleted of Macrophages
Galarneau, H., Villeneuve, J., Gowing, G., Julien, J.-P., & Vallières, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0177 · Cited by 113
“Because this synthetic glucocorticoid can suppress cytokine signaling and induce T cell apoptosis (31, 32), it may be useful to develop a more specific drug able to mimic dexamethasone’s beneficial properties without affecting the antitumor immune mechanisms.”
Glucocorticoid receptors modulate auditory sensitivity to acoustic trauma
Canlon, B., Meltser, I., Johansson, P. J., & Tahera, Y. (2006) · Hearing Research · doi:10.1016/j.heares.2006.05.009 · Cited by 111
Tokudome, S., Sano, M., Shinmura, K., Matsuhashi, T., Morizane, S., Moriyama, H., Tamaki, K., Hayashida, K., Nakanishi, H., Yoshikawa, N., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37413 · Cited by 117
Anti-inflammatory glucocorticoids: Changing concepts
Newton, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.035 · Cited by 118
Gravett, M. G., Waldorf, K. M. A., Sadowsky, D. W., Grosvenor, A. R., Witkin, S. S., Axthelm, M. K., & Novy, M. J. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.03.064 · Cited by 111
Majdalawieh, A. F., & Ro, J. (2010) · Mediators of Inflammation · doi:10.1155/2010/823821 · Cited by 124
Turrin, N. P., & Rivest, S. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901003 · Cited by 107
Staab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 122
Leukocyte adhesion and the pathophysiology of sickle cell disease
Okpala, I. E. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000190108.62414.06 · Cited by 116
Comprehensive Insights into Keloid Pathogenesis and Advanced Therapeutic Strategies
Kim, H. J., & Kim, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168776 · Cited by 116
Transrepression of Estrogen Receptor β Signaling by Nuclear Factor-κB in Ovarian Granulosa Cells
Chu, S., Nishi, Y., Yanase, T., Nawata, H., & Fuller, P. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0021 · Cited by 110
Frijters, R., Fleuren, W., Toonen, E. J., Tuckermann, J. P., Reichardt, H. M., van der Maaden, H., van Elsas, A., van Lierop, M.-J., Dokter, W., de Vlieg, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-359 · Cited by 103
“complex, which prevents expression of pro-inflammatory genes [7-16].”
BackgroundRegulation of S100A8 by Glucocorticoids
Hsu, K., Passey, R. J., Endoh, Y., Rahimi, F., Youssef, P., Yen, T., & Geczy, C. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2318 · Cited by 102
“GCs can alter mRNA stability (21), but there are no reports demonstrating increased stability of inducible S100 transcripts, as described here for mA8.”
BackgroundInfluentialRole of necroptosis in kidney health and disease
Kolbrink, B., von Samson‐Himmelstjerna, F. A., Murphy, J. M., & Krautwald, S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00658-w · Cited by 106
Asada, M., Rauch, A., Shimizu, H., Maruyama, H., Miyaki, S., Shibamori, M., Kawasome, H., Ishiyama, H., Tuckermann, J., & Asahara, H. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.170 · Cited by 105
Corticosteroid Receptor Genetic Polymorphisms and Stress Responsivity
DeRijk, R. H., & de Kloet, E. R. (2005) · Endocrine · doi:10.1385/endo:28:3:263 · Cited by 114
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
Abduljabbar, R. F., Negm, O. H., Lai, C., Jerjees, D. A., Al-kaabi, M. M., Hamed, M. R., Tighe, P. J., Buluwela, L., Mukherjee, A., Green, A. R., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3335-1 · Cited by 111
“Concomitantly, the survival effect of GR in breast cancers is activated through NF-jB activation signalling and induction of anti-apoptotic genes, such as inhibitors of apoptosis proteins (IAPs) [13, 54, 55].”
BackgroundRepression of DNA-binding dependent glucocorticoid receptor-mediated gene expression
Muzikar, K. A., Nickols, N. G., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909192106 · Cited by 101
“Additionally, the GR has been shown to exert its actions through an indirect non–DNA-binding mechanism, termed transrepression, in which transcriptional modulation is achieved through cross-talk between GR and other transcription factors such as NF- B (3), activator protein-1 (AP-1) (4, 5), Sma and Mad-related protein…”
BackgroundInfluentialRibosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Puri, M., Kaur, I., Kanwar, J. R., Gupta, R., Chauhan, A., & Kanwar, J. R. (2009) · Current Molecular Medicine · doi:10.2174/156652409789839071 · Cited by 102
NF-κB in carcinoma therapy and prevention
Brown, M. S., Cohen, J., Arun, P., Chen, Z., & Waes, C. V. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.9.1109 · Cited by 107
Glucocorticoid receptors in human airways
Pujols, L., Mullol, J., Torrego, A., & Picado, C. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00635.x · Cited by 98
“Other post-translational modifications that have been shown to alter GR function are ubiquitinylation, sumoylation and nitrosylation (24, 25).”
BackgroundGoing nuclear in metabolic and cardiovascular disease
Glass, C. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27913 · Cited by 111
Mandal, S. M., Hegde, M. L., Chatterjee, A., Hegde, P. M., Szczesny, B., Banerjee, D., Boldogh, I., Gao, R., Falkenberg, M., Gustafsson, C. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272179 · Cited by 96
Döll, F., Pfeilschifter, J. M., & Huwiler, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.001 · Cited by 106
The molecular complexity of glucocorticoid actions in inflammation — a four-ring circus
Goulding, N. J. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.06.009 · Cited by 115
Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., & Palvimo, J. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1033 · Cited by 90
“Interestingly, no AP-1 - or NF-kB-binding motifs were found to be enriched in the GRBs associated with the dex-repressed genes in the wtGR or the GR3KR cells.”
BackgroundResultInfluentialBosscher, K. D., Craenenbroeck, K. V., Meijer, O. C., & Haegeman, G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.076 · Cited by 106
Self-citationAltered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF‐κB inhibition
Beck, I. M. E., Berghe, W. V., Vermeulen, L., Bougarne, N., Cruyssen, B. V., Haegeman, G., & Bosscher, K. D. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.95 · Cited by 109
Self-citationWang, T., Holland, J. W., Carrington, A. C., Zou, J., & Secombes, C. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1475 · Cited by 99
“2 site (63), 13 IFN- -responsive element ( -IRE) sites (64), 10 GM-CSF sites (a repeated sequence CATT(A/T) required for GM-CSF promoter activity) (65), 2 GCF (66), glucocorticoid receptor (GR), NF-IL-6 and NF- B binding sites (67), 1 c-Myc and 1 Myb (68) binding site (Fig.”
BackgroundTCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38–MAPK-dependent pathway
Weiß, C., Faust, D., Dürk, H., Kolluri, S. K., Pelzer, A., Schneider, S., Dietrich, C., Oesch, F., & Göttlicher, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208679 · Cited by 105
Fürst, R., Schroeder, T., Eilken, H. M., Bubik, M. F., Kiemer, A. K., Zahler, S., & Vollmar, A. M. (2007) · The FASEB Journal · doi:10.1096/fj.06-6752com · Cited by 95
“It is commonly accepted that the up-regulation of E-selectin in activated endothelial cells is an NF-B-regulated event (16) and that Dex interferes with the NF-B pathway ( 17 ).”
BackgroundNehmé, A., & Edelman, J. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0273 · Cited by 110
Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells
Tissing, W. J. E., den Boer, M. L., Meijerink, J. P. P., Menezes, R. X., Swagemakers, S., van der Spek, P. J., Sallan, S. E., Armstrong, S. A., & Pieters, R. (2007) · Blood · doi:10.1182/blood-2006-11-056366 · Cited by 94
Glucocorticoids Increase Excitotoxic Injury and Inflammation in the Hippocampus of Adult Male Rats
Sorrells, S. F., Munhoz, C. D., Manley, N. C., Yen, S., & Sapolsky, R. M. (2014) · Neuroendocrinology · doi:10.1159/000367849 · Cited by 97
Structure–function relationships in the mineralocorticoid receptor
Pippal, J. B., & Fuller, P. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0093 · Cited by 101
“inflammatory response[ 81 ]. In contrast to the GR, the MR does not interact with the”
BackgroundHepataprotective effects of ginsenoside Rg1 – A review
Gao, Y., Chu, S., Zhang, Z., & Chen, N. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.04.012 · Cited by 97
King, E. M., Chivers, J. E., Rider, C. F., Minnich, A., Giembycz, M. A., & Newton, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053936 · Cited by 102
“In this regard, multiple mechanisms of transrepression are established [5].”
BackgroundInfluentialGlucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
Bereshchenko, O., Migliorati, G., Bruscoli, S., & Riccardi, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00308 · Cited by 100
“Most of the effects mediated by GCs, at physiological and pharmacological concentrations, are mediated by interactions with the glucocorticoid receptor (GR) (De Bosscher et al., 2003).”
BackgroundGenomic and non-genomic actions of glucocorticoids in asthma
Alangari, A. (2010) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.65040 · Cited by 101
“Annals of Thoracic Medicine - Vol 5, Issue 3, July-September 2010 135 many important pro-inflammatory genes by binding to and inhibiting key transcription factors, like nuclear factor kappa B (NFkB) and activator protein 1 (AP-1), among others, a process called transrepression [Figure 1].[27] Classical gene targets of…”
BackgroundMarahatha, R., Gyawali, K., Sharma, K., Gyawali, N., Tandan, P., Adhikari, A., Timilsina, G., Bhattarai, S., Lamichhane, G., Acharya, A., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7138 · Cited by 95
Doni, A., Mantovani, G., Porta, C., Tuckermann, J. P., Reichardt, H. M., Kleiman, A., Sironi, M., Rubino, L., Pasqualini, F., Nebuloni, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805631200 · Cited by 100
SUMO wrestling with type 1 diabetes
Li, M., Guo, D., Isales, C. M., Eizirik, D. L., Atkinson, M. A., She, J., & Wang, C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0645-5 · Cited by 95
“Activated NFκB and AP-1, on the other hand, enhance the expression of many cytokines and chemokines that are repressed by GR [92].”
Corticosteroids, Pregnancy, and HELLP Syndrome: A Review
Heimel, P. J. V. R., Franx, A., Schobben, A. F. A. M., Huisjes, A. J. M., Derks, J. B., & Bruinse, H. W. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000150346.42901.07 · Cited by 97
“AP-1 and NF- B are regulators of many inducible genes involved in immune and inflammatory responses (42,43).”
Background
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.